Splenectomy Impact and Outcome Among Patients With Sickle Cell Disease: A Cross‐Sectional Study
Health Science Reports · 2026-07 · 9 (7)
DOI: 10.1002/hsr2.72778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 07.07.2026. Verfasst von Mortadah Alsalman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine King Faisal University Al Ahsa Saudi Arabia. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
It is common to perform a splenectomy for patients with sickle cell disease (SCD); however, our understanding of its impact on long‐term clinical outcomes remains incomplete.
Objectives
To evaluate the clinical outcomes of splenectomy in SCD patients and to assess perioperative physician practices.
Methods
This is a retrospective cross‐sectional study that involved 245 adult Saudi patients with SCD, categorized into two groups: 40 patients who underwent splenectomy and 205 who did not. Data were gathered by structured interviews and electronic health records, including sociodemographic information, features of SCD, surgical procedures, and post‐splenectomy outcomes.
Results
The splenectomy group exhibited an increased frequency of acute chest syndrome (40% vs. 8.3%) and annual hospital admissions (8.7 vs. 3.35) due to pain crises before splenectomy. Following splenectomy, they demonstrated a notable decrease in hospital admissions and the need for blood transfusions (92.5% vs. 97.1%, 82.5% vs. 84.9%, respectively). Nevertheless, they exhibited a greater prevalence of stroke, venous thrombosis, and acute chest syndrome compared to the non‐splenectomy group (15% vs. 2.4%, 12.5% vs. 2.9%, and 45% vs. 8.3%). Patients aged ≤ 33 years ( p = 0.03) and those with comorbidities ( p = 0.02) demonstrated a significant response to splenectomy.
Conclusion
Splenectomy in SCD patients may result in reduced hospital admissions and blood transfusion needs. Yet, it may elevate the risk of thromboembolic events and acute chest syndrome. Optimizing outcomes require careful patient selection and perioperative management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine King Faisal University Al Ahsa Saudi Arabia.
- College of Medicine King Faisal University Al Ahsa Saudi Arabia.
- Department of Family and Community Medicine Al Ahsa Health Cluster Al Ahsa Saudi Arabia.
- Department of Intensive Care Mouwasat Hospital Saudi Arabia.
- Faculty of Medicine Menoufia University Shebin Elkom Egypt.
- Department of Surgery, College of Medicine King Faisal University Al Ahsa Saudi Arabia.
ORCID-Profile: Mortadah Alsalman, Mohammed Alessa, Somaia Shehab-Eldeen
Zitieren
APA
Alsalman, M., Bu-Khamsin, Z., AlSahaf, F., Amer, F. A., Alhelal, F., Essa, A., Alessa, M., Shehab-Eldeen, S., & Essa, A. (2026). Splenectomy Impact and Outcome Among Patients With Sickle Cell Disease: A Cross‐Sectional Study. Health Science Reports, 9(7). https://doi.org/10.1002/hsr2.72778
Vancouver
Alsalman M, Bu-Khamsin Z, AlSahaf F, Amer FA, Alhelal F, Essa A, et al. Splenectomy Impact and Outcome Among Patients With Sickle Cell Disease: A Cross‐Sectional Study. Health Science Reports. 2026;9(7). doi:10.1002/hsr2.72778
BibTeX
@article{Alsalman2026,
author = {Alsalman, Mortadah and Bu-Khamsin, Zainab and AlSahaf, Fatimah and Amer, Fatima Al and Alhelal, Fatema and Essa, Ali and Alessa, Mohammed and Shehab-Eldeen, Somaia and Essa, Abdallah},
title = {Splenectomy Impact and Outcome Among Patients With Sickle Cell Disease: A Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {7},
doi = {10.1002/hsr2.72778}
}
EUVIMED